Aagami's CEO Dinesh Jain and Head BD Ed Steinhardt attended the Biotech Industry Organization (BIO) 2012 annual convention in Boston.Both were quite b...
Published : 05 Jun 2012
Read MoreToday our Melbourne based publicly listed client received their second success in Out-licensing their drug delivery technology for 3 anti-aging formul...
Published : 04 Apr 2012
Read MoreA nanotechnology based Diagnostic technology platform company, which has evolved from top notch Brazilian university, today retained Aagami for its li...
Published : 15 Feb 2012
Read MoreAagami has been contracted to work for a biotechnology company based in Barcelona to find co-development, licensing and investment partners from India...
Published : 05 Feb 2012
Read MoreA Oregon drug development company, with innovative technology licensed from Portland State University, is developing 3 projects pipeline two antimalar...
Published : 16 Jan 2012
Read MoreIn January 2012, Dinesh Jain CEO of Aagami and Ed Steinhardt Head BD will go to San Francisco for attending J P Morgan Healthcare conference and Biote...
Published : 27 Dec 2011
Read MoreAagami client AdvanGene today signed the distribution agreement with Gangwal Chemicals Pvt. Ltd. of Mumbai India.AdvanGene is Chicago area based...
Published : 12 Dec 2011
Read MoreAagami has organized a 10 days partnering trip for CEO and CSO of its German client that have Protein Therapeutic new class of molecules in developmen...
Published : 05 Dec 2011
Read MoreToday Aagami received an assignment from a clinical-stage oncology drug development company from Canada, focused on commercializing new treatments for...
Published : 01 Dec 2011
Read MoreDinesh Jain, Founder CEO of Aagami is leaving for Germany to attend CPhI 2012 in Frankfurt and BIO Europe 2012 in Dusseldorf.Aagami has had several Eu...
Published : 22 Oct 2011
Read More